Report Detail
Global Diabetic Gastroparesis Treatment Market Insights, Forecast to 2025
- RnM2883374 |
- 14 February, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
The global Diabetic Gastroparesis Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Diabetic Gastroparesis Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Diabetic Gastroparesis Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Diabetic Gastroparesis Treatment in these regions.
This research report categorizes the global Diabetic Gastroparesis Treatment market by top players/brands, region, type and end user. This report also studies the global Diabetic Gastroparesis Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Janssen Global Services, LLC
Evoke Pharma
Cardinal Health, Inc.
Salix Pharmaceuticals, Inc.
Alfa Wassermann SPA
Abbott Laboratories
Medtronic Plc.
C. R. Bard, Inc.
Rhythm Pharmaceuticals, Inc.
Boston Scientific Corporation
Kimberly-Clark Corporation
Market size by Product
Gastroprokinetic Agents
Antiemetic Agents
Botulinum Toxin
Market size by End User
Compensated Gastroparesis
Gastric Failure
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Diabetic Gastroparesis Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Diabetic Gastroparesis Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Diabetic Gastroparesis Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Diabetic Gastroparesis Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Diabetic Gastroparesis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Diabetic Gastroparesis Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Diabetic Gastroparesis Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Diabetic Gastroparesis Treatment Market Size Growth Rate by Product
- 1.4.2 Gastroprokinetic Agents
- 1.4.3 Antiemetic Agents
- 1.4.4 Botulinum Toxin
- 1.5 Market by End User
- 1.5.1 Global Diabetic Gastroparesis Treatment Market Size Growth Rate by End User
- 1.5.2 Compensated Gastroparesis
- 1.5.3 Gastric Failure
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Diabetic Gastroparesis Treatment Market Size
- 2.1.1 Global Diabetic Gastroparesis Treatment Revenue 2014-2025
- 2.1.2 Global Diabetic Gastroparesis Treatment Sales 2014-2025
- 2.2 Diabetic Gastroparesis Treatment Growth Rate by Regions
- 2.2.1 Global Diabetic Gastroparesis Treatment Sales by Regions
- 2.2.2 Global Diabetic Gastroparesis Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Diabetic Gastroparesis Treatment Sales by Manufacturers
- 3.1.1 Diabetic Gastroparesis Treatment Sales by Manufacturers
- 3.1.2 Diabetic Gastroparesis Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Diabetic Gastroparesis Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Diabetic Gastroparesis Treatment Revenue by Manufacturers
- 3.2.1 Diabetic Gastroparesis Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Diabetic Gastroparesis Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Diabetic Gastroparesis Treatment Price by Manufacturers
- 3.4 Diabetic Gastroparesis Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Diabetic Gastroparesis Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Diabetic Gastroparesis Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Diabetic Gastroparesis Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Diabetic Gastroparesis Treatment Sales by Product
- 4.2 Global Diabetic Gastroparesis Treatment Revenue by Product
- 4.3 Diabetic Gastroparesis Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Diabetic Gastroparesis Treatment Breakdown Data by End User
6 North America
- 6.1 North America Diabetic Gastroparesis Treatment by Countries
- 6.1.1 North America Diabetic Gastroparesis Treatment Sales by Countries
- 6.1.2 North America Diabetic Gastroparesis Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Diabetic Gastroparesis Treatment by Product
- 6.3 North America Diabetic Gastroparesis Treatment by End User
7 Europe
- 7.1 Europe Diabetic Gastroparesis Treatment by Countries
- 7.1.1 Europe Diabetic Gastroparesis Treatment Sales by Countries
- 7.1.2 Europe Diabetic Gastroparesis Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Diabetic Gastroparesis Treatment by Product
- 7.3 Europe Diabetic Gastroparesis Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Diabetic Gastroparesis Treatment by Countries
- 8.1.1 Asia Pacific Diabetic Gastroparesis Treatment Sales by Countries
- 8.1.2 Asia Pacific Diabetic Gastroparesis Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Diabetic Gastroparesis Treatment by Product
- 8.3 Asia Pacific Diabetic Gastroparesis Treatment by End User
9 Central & South America
- 9.1 Central & South America Diabetic Gastroparesis Treatment by Countries
- 9.1.1 Central & South America Diabetic Gastroparesis Treatment Sales by Countries
- 9.1.2 Central & South America Diabetic Gastroparesis Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Diabetic Gastroparesis Treatment by Product
- 9.3 Central & South America Diabetic Gastroparesis Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Diabetic Gastroparesis Treatment by Countries
- 10.1.1 Middle East and Africa Diabetic Gastroparesis Treatment Sales by Countries
- 10.1.2 Middle East and Africa Diabetic Gastroparesis Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Diabetic Gastroparesis Treatment by Product
- 10.3 Middle East and Africa Diabetic Gastroparesis Treatment by End User
11 Company Profiles
- 11.1 Janssen Global Services, LLC
- 11.1.1 Janssen Global Services, LLC Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Janssen Global Services, LLC Diabetic Gastroparesis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Janssen Global Services, LLC Diabetic Gastroparesis Treatment Products Offered
- 11.1.5 Janssen Global Services, LLC Recent Development
- 11.2 Evoke Pharma
- 11.2.1 Evoke Pharma Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Evoke Pharma Diabetic Gastroparesis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Evoke Pharma Diabetic Gastroparesis Treatment Products Offered
- 11.2.5 Evoke Pharma Recent Development
- 11.3 Cardinal Health, Inc.
- 11.3.1 Cardinal Health, Inc. Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Cardinal Health, Inc. Diabetic Gastroparesis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Cardinal Health, Inc. Diabetic Gastroparesis Treatment Products Offered
- 11.3.5 Cardinal Health, Inc. Recent Development
- 11.4 Salix Pharmaceuticals, Inc.
- 11.4.1 Salix Pharmaceuticals, Inc. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Products Offered
- 11.4.5 Salix Pharmaceuticals, Inc. Recent Development
- 11.5 Alfa Wassermann SPA
- 11.5.1 Alfa Wassermann SPA Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Alfa Wassermann SPA Diabetic Gastroparesis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Alfa Wassermann SPA Diabetic Gastroparesis Treatment Products Offered
- 11.5.5 Alfa Wassermann SPA Recent Development
- 11.6 Abbott Laboratories
- 11.6.1 Abbott Laboratories Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Abbott Laboratories Diabetic Gastroparesis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Abbott Laboratories Diabetic Gastroparesis Treatment Products Offered
- 11.6.5 Abbott Laboratories Recent Development
- 11.7 Medtronic Plc.
- 11.7.1 Medtronic Plc. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Medtronic Plc. Diabetic Gastroparesis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Medtronic Plc. Diabetic Gastroparesis Treatment Products Offered
- 11.7.5 Medtronic Plc. Recent Development
- 11.8 C. R. Bard, Inc.
- 11.8.1 C. R. Bard, Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 C. R. Bard, Inc. Diabetic Gastroparesis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 C. R. Bard, Inc. Diabetic Gastroparesis Treatment Products Offered
- 11.8.5 C. R. Bard, Inc. Recent Development
- 11.9 Rhythm Pharmaceuticals, Inc.
- 11.9.1 Rhythm Pharmaceuticals, Inc. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Products Offered
- 11.9.5 Rhythm Pharmaceuticals, Inc. Recent Development
- 11.10 Boston Scientific Corporation
- 11.10.1 Boston Scientific Corporation Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Boston Scientific Corporation Diabetic Gastroparesis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Boston Scientific Corporation Diabetic Gastroparesis Treatment Products Offered
- 11.10.5 Boston Scientific Corporation Recent Development
- 11.11 Kimberly-Clark Corporation
12 Future Forecast
- 12.1 Diabetic Gastroparesis Treatment Market Forecast by Regions
- 12.1.1 Global Diabetic Gastroparesis Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Diabetic Gastroparesis Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Diabetic Gastroparesis Treatment Market Forecast by Product
- 12.2.1 Global Diabetic Gastroparesis Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Diabetic Gastroparesis Treatment Revenue Forecast by Product 2019-2025
- 12.3 Diabetic Gastroparesis Treatment Market Forecast by End User
- 12.4 North America Diabetic Gastroparesis Treatment Forecast
- 12.5 Europe Diabetic Gastroparesis Treatment Forecast
- 12.6 Asia Pacific Diabetic Gastroparesis Treatment Forecast
- 12.7 Central & South America Diabetic Gastroparesis Treatment Forecast
- 12.8 Middle East and Africa Diabetic Gastroparesis Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Diabetic Gastroparesis Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Diabetic Gastroparesis Treatment . Industry analysis & Market Report on Diabetic Gastroparesis Treatment is a syndicated market report, published as Global Diabetic Gastroparesis Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Diabetic Gastroparesis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
